|
| | Publication Year | Title | Author(s) |
| 21 | 31-Jan-2023 | Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. | Herbst, Roy S; Wu, Yi-Long; John, Thomas ; Grohe, Christian; Majem, Margarita; Wang, Jie; Kato, Terufumi; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Yu, Chong-Jen; Vu, Huu Vinh; Lu, Shun; Lee, Kye Young; Mukhametshina, Guzel; Akewanlop, Charuwan; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Urban, Damien; Huang, Xiangning; Bolanos, Ana; Stachowiak, Marta; Tsuboi, Masahiro |
| 22 | May-2022 | Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage. | Balasubramanian, Adithya ; Gunjur, Ashray ; Weickhardt, Andrew J ; Papa, Nathan; Bolton, Damien M ; Lawrentschuk, Nathan; Perera, Marlon |
| 23 | Apr-2018 | Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis. | Tang, Monica; Price, Timothy Jay; Shapiro, Jeremy; Gibbs, Peter; Haller, Daniel G; Arnold, Dirk; Peeters, Marc; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew |
| 24 | Aug-2022 | Adult medulloblastoma in an Australian population. | Parakh, Sagun ; Davies, Amy; Westcott, Kerryn; Roos, Daniel; Abou-Hamden, Amal; Ahern, Elizabeth; Lau, Peter K H; Cheruvu, Sowmya; Pranavan, Ganesalingam; Pullar, Andrew; Lynam, James; Gzell, Cecelia; Whittle, James R; Cain, Sarah; Inglis, Po-Ling; Harrup, Rosemary; Anazodo, Antoinette; Hovey, Elizabeth; Cher, Lawrence M ; Gan, Hui K |
| 25 | Jan-2016 | Aggregated adverse-events outcomes in oncology phase III reports: A systematic review. | Maillet, Denis; Gan, Hui K ; Blay, Jean-Yves; You, Benoit; Péron, Julien |
| 26 | 1-Dec-2017 | ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer. | Pietrantonio, Filippo; Di Nicolantonio, Federica; Schrock, Alexa B; Lee, Jeeyun; Tejpar, Sabine; Sartore-Bianchi, Andrea; Hechtman, Jaclyn F; Christiansen, Jason; Novara, Luca; Tebbutt, Niall C ; Fucà, Giovanni; Antoniotti, Carlotta; Kim, Seung Tae; Murphy, Danielle; Berenato, Rosa; Morano, Federica; Sun, James; Min, Bosun; Stephens, Philip J; Chen, Marissa; Lazzari, Luca; Miller, Vincent A; Shoemaker, Robert; Amatu, Alessio; Milione, Massimo; Ross, Jeffrey S; Siena, Salvatore; Bardelli, Alberto; Ali, Siraj M; Falcone, Alfredo; de Braud, Filippo; Cremolini, Chiara |
| 27 | 2-Aug-2021 | Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. | Park, Keunchil; Haura, Eric B; Leighl, Natasha B; Mitchell, Paul L R ; Shu, Catherine A; Girard, Nicolas; Viteri, Santiago; Han, Ji-Youn; Kim, Sang-We; Lee, Chee Khoon; Sabari, Joshua K; Spira, Alexander I; Yang, Tsung-Ying; Kim, Dong-Wan; Lee, Ki Hyeong; Sanborn, Rachel E; Trigo, José; Goto, Koichi; Lee, Jong-Seok; Yang, James Chih-Hsin; Govindan, Ramaswamy; Bauml, Joshua M; Garrido, Pilar; Krebs, Matthew G; Reckamp, Karen L; Xie, John; Curtin, Joshua C; Haddish-Berhane, Nahor; Roshak, Amy; Millington, Dawn; Lorenzini, Patricia; Thayu, Meena; Knoblauch, Roland E; Cho, Byoung Chul |
| 28 | 27-Feb-2023 | Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial. | Chmielecki, Juliann; Mok, Tony; Wu, Yi-Long; Han, Ji-Youn; Ahn, Myung-Ju; Ramalingam, Suresh S; John, Thomas ; Okamoto, Isamu; Yang, James Chih-Hsin; Shepherd, Frances A; Bulusu, Krishna C; Laus, Gianluca; Collins, Barbara; Barrett, J Carl; Hartmaier, Ryan J; Papadimitrakopoulou, Vassiliki |
| 29 | Dec-2020 | Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort. | Chia, Puey Ling ; Russell, Prudence; Asadi, Khashi; Thapa, Bibhusal ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Eriksson, Ulf; Scott, Andrew M ; John, Thomas |
| 30 | 1-Feb-2017 | Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. | Menzies, A M; Johnson, D B; Ramanujam, S; Atkinson, V G; Wong, A N M; Park, J J; McQuade, J L; Shoushtari, A N; Tsai, K K; Eroglu, Z; Klein, Oliver ; Hassel, J C; Sosman, J A; Guminski, A; Sullivan, R J; Ribas, A; Carlino, M S; Davies, M A; Sandhu, S K; Long, G V |
| 31 | 5-Sep-2019 | Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature. | Gunjur, Ashray ; Klein, Oliver ; Kee, Damien ; Cebon, Jonathan S |
| 32 | 5-Apr-2011 | Antibodies in oncology. | Pillay, Vinochani; Gan, Hui K ; Scott, Andrew M |
| 33 | 13-Nov-2023 | Antibody drug conjugates for glioblastoma: current progress toward clinical use. | Gan, Hui K ; Parakh, Sagun ; Osellame, Laura D; Cher, Lawrence M ; Uccellini, Anthony; Hafeez, Umbreen ; Menon, Siddharth; Scott, Andrew M |
| 34 | 3-Dec-2021 | Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them? | Parakh, Sagun ; Nicolazzo, Joseph; Scott, Andrew M ; Gan, Hui K |
| 35 | 8-May-2020 | Antibody Targeting of Eph Receptors in Cancer. | Janes, Peter W ; Vail, Mary E; Gan, Hui K ; Scott, Andrew M |
| 36 | 11-Jul-2016 | Antibody-Drug Conjugates for Cancer Therapy. | Parslow, Adam C; Parakh, Sagun ; Lee, Fook-Thean; Gan, Hui K ; Scott, Andrew M |
| 37 | 16-Oct-2020 | Antibody-Drug Conjugates for Cancer Therapy. | Hafeez, Umbreen ; Parakh, Sagun ; Gan, Hui K ; Scott, Andrew M |
| 38 | Nov-2017 | Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells. | Gan, Hui K ; van den Bent, Martin; Lassman, Andrew B; Reardon, David A; Scott, Andrew M |
| 39 | 2022 | Antibody-drug conjugates: beyond current approvals and potential future strategies. | Menon, Siddharth; Parakh, Sagun ; Scott, Andrew M ; Gan, Hui K |
| 40 | 2016 | Antibody-mediated delivery of therapeutics for cancer therapy | Parakh, Sagun ; Parslow, Adam C; Gan, Hui K ; Scott, Andrew M |
